Trial Profile
A randomized, double-blind study of the safety and efficacy of MC4 Agonist, compared to that of sildenafil, in patients with male erectile dysfunction.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Feb 2010
Price :
$35
*
At a glance
- Drugs Melanocortin type 4 receptor agonists; Sildenafil
- Indications Erectile dysfunction
- Focus Adverse reactions; Therapeutic Use
- Sponsors Roche
- 26 Feb 2010 New trial record